A Maintenance Therapy Study of Odetiglucan With CDX-1140 in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

NCT05484011 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Stopped sponsor decision

Conditions

Metastatic Pancreatic Adenocarcinoma

Interventions

BIOLOGICAL: odetiglucan
BIOLOGICAL: CDX-1140

Sponsor

HiberCell, Inc.

Collaborators

[object Object]